These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4198349)

  • 21. Antituberculosis activity of rifampin. Report of studies performed and in progress (1966-1971).
    Nitti V
    Chest; 1972 Jun; 61(6):589-98. PubMed ID: 4624281
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative tests with old tuberculin in sanatorium practice.
    Woodruff CE; Chapman PT; Howard WL; Klopfenstein MD; Steininger WJ
    Am Rev Respir Dis; 1968 Aug; 98(2):270-6. PubMed ID: 4970048
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative data on the study of single and fractional use of antitubercular agents of the first order in the treatment of tuberculosis in children and adolescents].
    Firsova VA; Kupish SG; Ivanova AI; Maslauskene TP; Novruzov MA
    Vopr Okhr Materin Det; 1976; 21(3):52-4. PubMed ID: 1086033
    [No Abstract]   [Full Text] [Related]  

  • 24. Follow-up of positive cases of pulmonary tuberculosis diagnosed in 1957.
    Christensen O
    Scand J Respir Dis Suppl; 1968; 63():9-28. PubMed ID: 4972112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 26. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 27. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
    Ramakrishnan CV; Devadatta S; Evans C; Fox W; Menon NK; Nazareth O; Radhakrishna S; Sambamoorthy S; Stott H; Tripathy SP; Velu S
    Tubercle; 1969 Jun; 50(2):115-24. PubMed ID: 4892322
    [No Abstract]   [Full Text] [Related]  

  • 28. The problem of the chronic excretor of tubercle bacilli.
    Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K
    Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247
    [No Abstract]   [Full Text] [Related]  

  • 29. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
    Yamamoto M; Nakamura H
    Kekkaku; 1971 Jun; 46(6):191-5. PubMed ID: 4997826
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 31. Intermittent chemotherapy or improvement of initial treatment in tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334
    [No Abstract]   [Full Text] [Related]  

  • 32. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of tuberculosis among the Orang Asli (Aborigines) in West Malaysia from 1951-1970.
    Bolton JM; Snelling MR
    Med J Malaysia; 1975 Sep; 30(1):10-29. PubMed ID: 813093
    [No Abstract]   [Full Text] [Related]  

  • 34. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAS.
    Tubercle; 1973 Jun; 54(2):165-7. PubMed ID: 4128919
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of early detected destructive pulmonary tuberculosis].
    Anfilof'eva OIu; fedotova ZN
    Probl Tuberk; 1974; (12):38-41. PubMed ID: 4445134
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immediate results obtained with intermittent treatment with classical tuberculostatic drugs in tuberculosis in children].
    Tonceanu S; Carp G; Bazacliu E; Sabău I
    Ftiziologia; 1974 May; 23(3):265-8. PubMed ID: 4546327
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethambutol treatment of tuberculosis in a controlled trial.
    Segarra FO; Lorian V; Sherman DS
    Scand J Respir Dis; 1968; 49(3):202-6. PubMed ID: 4980226
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombocytopenia following administration of para-aminosalicylic acid.
    Feigin RD; Zarkowsky HF; Shearer W; Anderson DC
    J Pediatr; 1973 Sep; 83(3):502-3. PubMed ID: 4541998
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.